Company Analysis

Abeona Therapeutics Inc. (ABEO)

Nasdaq: ABEO · Pharmaceutical Preparations · Cleveland, OH · filing with the SEC since 1995
Grade5.5
◀ Past 4.3● Present 5.5▶ Future 6.3
1 est.

Who runs Abeona Therapeutics Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Seshadri Vishwas
Chief Executive Officer. First filing Jun 2021, latest Sep 29, 2026, 14 filings in all.
Officers reporting now
6
of 13 people with a filing in the last fifteen months
Directors reporting now
7
30 people on the record since 2006
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Seshadri VishwasChief Executive OfficerJun 2021Sep 29, 20269 · $1.6M
Vazzano Joseph WalterChief Financial OfficerMar 2022Sep 29, 20268 · $600,000
O'Malley Brendan M.SVP, Chief Legal OfficerSep 2021Sep 29, 20265 · $300,000
Vasanthavada MadhavChief Commercial OfficerJan 2026Sep 29, 20266 · $300,000
Silverstein Christine BerniChief Financial OfficerApr 2019Jun 15, 20262 · $200,000
Amoroso MichaelChief Executive OfficerNov 2020Jan 27, 2026none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Alvino MarkdirectorMar 2006Sep 1, 20265 · $300,000
Alland LeiladirectorApr 2021Jul 2, 20262 · $200,000
Crombez EricdirectorAug 2024May 15, 20262 · $200,000
Goldan Keith A.directorApr 2026Apr 7, 2026none
Wuchterl Donald A.directorApr 2021Feb 2, 20261 · $100,000
Charles Faith L.directorApr 2021Jan 27, 2026none
Zeiher Bernhardt GdirectorAug 2024Jan 27, 2026none
Earlier names on the record22, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ABEO · research, not advice